Lv2
130 积分 2024-07-29 加入
Multiparametric MRI for Bladder Cancer: Validation of VI-RADS for the Detection of Detrusor Muscle Invasion
7小时前
待确认
The validity, reliability, and reviewer acceptance of VI-RADS in assessing muscle invasion by bladder cancer: a multicenter prospective study
19天前
已完结
Multiparametric MRI for Bladder Cancer: Validation of VI-RADS for the Detection of Detrusor Muscle Invasion
19天前
已完结
Development and Validation of a Contrast-Enhanced US VI-RADS for Evaluating Muscle Invasion in Bladder Cancer
28天前
已完结
First-Line Therapy For Advanced Non–Clear Cell Renal Cell Carcinoma
1个月前
已完结
Meta-analysis on SBRT and ablation for localised RCC
1个月前
已关闭
Validity and Efficiency of Progression-Free Survival-2 as a Surrogate End Point for Overall Survival in Advanced Cancer Randomized Trials
1个月前
已完结
Enfortumab Vedotin and Pembrolizumab — A New Perspective on Urothelial Cancer
5个月前
已完结
Enhancing the Pharmacokinetics and Antitumor Activity of an α-Amanitin-Based Small-Molecule Drug Conjugate via Conjugation with an Fc Domain
5个月前
已完结
Unlocking the mechanisms underlying the activity of pembrolizumab plus enfortumab vedotin in patients with urothelial carcinoma
5个月前
已完结
皖公网安备34019202002308
